Patents Assigned to NANO INTELLIGENT BIOMEDICAL ENGINEERING
-
Patent number: 11365218Abstract: Disclosed are a bifunctional peptide having the capability to reduce inflammation and the capability to facilitate differentiation of stem cells into chondrocytes and the use thereof. Advantageously, the bifunctional peptide is useful for the prevention or treatment of arthritis accompanied by inflammation and damage of cartilage tissue due to excellent effects of reducing inflammation and facilitating differentiation of stem cells into chondrocytes, can be easily applied to various surgical regenerative treatments including orthopedic treatments, and can shorten the treatment period.Type: GrantFiled: May 25, 2020Date of Patent: June 21, 2022Assignees: SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION, NANO INTELLIGENT BIOMEDICAL ENGINEERING CORPORATION CO. LTD.Inventors: Yoon Jeong Park, Chong-Pyoung Chung, Jue-Yeon Lee
-
Patent number: 11179445Abstract: The present invention relates to a pharmaceutical composition for preventing or treating bone diseases comprising a fusion peptide in which a bone tissue-selective peptide bound to parathyroid hormone (PTH) or a fragment thereof. More particularly, the present invention relates to a pharmaceutical composition and biomaterial for preventing or treating bone diseases comprising a fusion peptide in which a bone tissue-selective peptide represented by an amino acid sequence of SEQ ID NO. 3 bound to parathyroid hormone (PTH) or a fragment thereof represented by an amino acid sequence of SEQ ID NO. 4 or 5. The fusion peptide can improve effects of PTH by selectively binding to bone tissue and can reduce administration frequency by increasing the half-life. The fusion peptide can be used as a subcutaneous or intravenous injection-type pharmaceutical composition for treating osteoporosis and fracture, and can be used in combination with a medical device for tissue recovery to increase formation of bone tissue.Type: GrantFiled: November 29, 2017Date of Patent: November 23, 2021Assignees: NANO INTELLIGENT BIOMEDICAL ENGINEERING CORPORATION CO. LTD., SEOUL NATIONAL UNIVERSITY R&DB FOUNDATIONInventors: Yoon Jeong Park, Chong-Pyoung Chung, Jue-Yeon Lee
-
Patent number: 10836795Abstract: A peptide derived from the copine 7 protein and having both cell permeability and bone tissue regeneration ability, and a use of the peptide, are described. The peptide has excellent bone tissue regeneration ability and is therefore useful for treating a disease requiring bone regeneration, such as osteoporosis. Particularly, by also having cell permeability, the peptide does not require the attachment of a separate peptide or addition of another preparation for the cell permeation thereof and thus can be conveniently applied in orthopedics and the like requiring various surgical regeneration treatments.Type: GrantFiled: December 27, 2017Date of Patent: November 17, 2020Assignees: SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION, NANO INTELLIGENT BIOMEDICAL ENGINEERING CORPORATION CO. LTD.Inventors: Yoon Jeong Park, Chong-Pyoung Chung, Jue-Yeon Lee, Joocheol Park
-
Patent number: 10815312Abstract: Disclosed are a bifunctional peptide having the capability to permeate cells and the capability to regenerate muscles and the use thereof. Advantageously, the bifunctional peptide has a function of regenerating muscle cells and thus is useful for the prevention or treatment of diseases affecting muscle regeneration, and additionally has the capability to permeate cells and thus eliminates the necessity to adhere an additional peptide or add other agent or drug for cell permeation of the peptide, thereby finally exerting an efficient muscle generation effect. Thus, the bifunctional peptide can be easily applied to various surgical regenerative treatments and can shorten the treatment period.Type: GrantFiled: March 11, 2019Date of Patent: October 27, 2020Assignees: SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION, NANO INTELLIGENT BIOMEDICAL ENGINEERING CORPORATION CO. LTD.Inventors: Yoon Jeong Park, Chong-Pyoung Chung, Jue-Yeon Lee
-
Patent number: 10406264Abstract: The present invention relates to a peptide having the ability to bind specifically to the surface of titanium. The titanium-binding peptide according to the present invention is fixed securely to the titanium surface so that the activity of a physiologically active substance linked to the peptide can be stably maintained over a long period of time. Thus, the peptide can be effectively used for surgical regeneration therapy.Type: GrantFiled: March 7, 2017Date of Patent: September 10, 2019Assignees: NANO INTELLIGENT BIOMEDICAL ENGINEERING CORPORATION CO., LTD., Seoul National University R&DB FoundationInventors: Chong-Pyoung Chung, Yoon Jeong Park, Jue-Yeon Lee, Yeonsu Kim, Dong Woo Lee
-
Patent number: 10232083Abstract: Provided are a tissue structure mimetic used for regenerating a tissue and a method for manufacturing the same, and more particularly, a 3-dimensional tissue structure mimetic which consists of a complex of extracellular matrix protein and bone mineral, wherein the complex is specifically bound to a regeneration-functional peptide to thereby be capable of implementing environment of a tissue requiring restoration, and a method for manufacturing the same. In the tissue structure mimetic according to the present invention, bone mineral components are finely dispersed in the extracellular matrix protein to have excellent mechanical strength of the tissue structure mimetic and conductivity which provides a migration path of cells involved in tissue regeneration. Further, environment of the tissue may be implemented by the peptide contained in the tissue structure mimetic to finally remarkably increase tissue regeneration capacity.Type: GrantFiled: April 1, 2014Date of Patent: March 19, 2019Assignee: NANO INTELLIGENT BIOMEDICAL ENGINEERING CORPORATION CO. LTD.Inventors: Chong-Pyoung Chung, Yoon Jeong Park, Jue-Yeon Lee
-
Patent number: 10155022Abstract: The disclosure relates to a fat accumulation inhibitory peptide which essentially comprises an amino acid sequence represented by SEQ ID NO: 1, a pharmaceutical composition for preventing or treating obesity, which contains the peptide, and a health functional food for preventing or alleviating obesity, which contains the peptide. The fat accumulation inhibitory peptide according to the present invention has the function of inhibiting the differentiation of mesenchymal stem cells into adipocytes to thereby inhibit the accumulation of adipose tissue. Thus, the peptide according to the present invention is highly useful for the prevention or treatment of obesity.Type: GrantFiled: August 1, 2017Date of Patent: December 18, 2018Assignees: SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION, NANO INTELLIGENT BIOMEDICAL ENGINEERING CORPORATION CO. LTD.Inventors: Chong-Pyoung Chung, Yoon Jeong Park, Jue-Yeon Lee, Jin Sook Suh, In Ho Jo, Yoon Shin Park
-
Patent number: 9993519Abstract: The present invention relates to an anticancer composition comprising a peptide that inhibits the proliferation of cancer stem cells present in tumor tissue and that induces apoptosis of such cancer stem cells, and more particularly, to an anticancer peptide that inhibits the activity of NF-?B which is overexpressed specifically in cancer stem cells present in tumors.Type: GrantFiled: March 3, 2016Date of Patent: June 12, 2018Assignees: SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION, NANO INTELLIGENT BIOMEDICAL ENGINEERING CORPORATION CO., LTD.Inventors: Yoon Jeong Park, Chong-Pyoung Chung, Jue-Yeon Lee, Jin Sook Suh
-
Patent number: 9849190Abstract: A method of treating breast cancer is described, in which a peptide having cancer selective translocation function-doxoribicin conjugate is administered. The conjugate includes doxorubicin chemically linked to the N-terminus or C-terminus of a VEGF-binding protein transduction domain (VPTD) peptide represented as SEQ ID NO: 1, wherein the VPTD peptide and doxorubicin are linked to each other by a disulfide bond, and wherein the VPTD peptide binds specifically to vascular endothelial growth factor (VEGF) in tumor cells or tumor tissues.Type: GrantFiled: August 11, 2016Date of Patent: December 26, 2017Assignees: SNU R&DB FOUNDATION, NANO INTELLIGENT BIOMEDICAL ENGINEERING CORPORATION CO, LTD.Inventors: Yoon Jeong Park, Chong-Pyoung Chung, Jin Sook Suh, Yoon Jung Choi
-
Patent number: 9801973Abstract: The present invention relates to a peptide that binds specifically to the surface of zirconia, and more particularly, to a peptide conjugate obtained by linking a functional drug to the peptide so as to enable the drug to be securely fixed to the surface of zirconia to thereby maintain the activity of the drug over a long period of time. The zirconia-binding peptide according to the present invention can be securely fixed to the surface of zirconia so that the activity of a physiologically active substance introduced into the peptide can be maintained on the zirconia surface over a long period of time. Thus, the zirconia-binding peptide is useful for surgical regenerative treatment.Type: GrantFiled: April 5, 2016Date of Patent: October 31, 2017Assignees: SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION, NANO INTELLIGENT BIOMEDICAL ENGINEERING CORPORATION CO. LTD.Inventors: Yoon Jeong Park, Jin Sook Suh, Chong-Pyoung Chung, Jue-Yeon Lee, Yeonsu Kim
-
Patent number: 9644185Abstract: A method of preparing a reprogramming induced pluripotent stem cell from a human-derived somatic cell using a fusion protein in which a reprogramming inducing factor and cell permeable peptide (CPP) are fused, and a fusion protein in which a reprogramming inducing factor and a cell permeable peptide are fused are disclosed. According to the present invention, the induced pluripotent stem cell having high efficiency and high stability can be prepared by maximizing the effect of the reprogramming inducing transcription factor beyond the existing viral peptide transporter, in inducing the reprogramming of the somatic cell.Type: GrantFiled: August 27, 2014Date of Patent: May 9, 2017Assignees: SNU R&DB FOUNDATION, NANO INTELLIGENT BIOMEDICAL ENGINEERING CORPORATION CO. LTD.Inventors: Yoon Jeong Park, Gene Lee, Hyun Nam, Jin Sook Suh, Chong-Pyoung Chung, Jue-Yeon Lee
-
Patent number: 9408920Abstract: The present invention relates to a cell permeable fusion protein for strengthening regenerative potential of stem cells, and more particularly to a cell permeable fusion protein for strengthening regenerative potential of stem cells for stimulating the differentiation of stem cells, inhibiting apoptosis, maintaining the functionality of stem cells and restoring the stress-inhibited functionality of stem cells.Type: GrantFiled: December 16, 2011Date of Patent: August 9, 2016Assignees: SEOUL NATIONAL UNIVERSITY R AND DB FOUNDATION, NANO INTELLIGENT BIOMEDICAL ENGINEERING CORPORATION CO, LTD.Inventors: Chong-Pyoung Chung, Yoon-Jeong Park, Jue-Yeon Lee
-
Patent number: 9133246Abstract: A collagen membrane having fusion protein bound thereto is described, in which the fusion protein includes collagen binding peptide and antibacterial peptide. The collagen membrane is usefully employed in vivo to promote cell migration, proliferation, and differentiation associated with bone tissue regeneration, for bone induction and regeneration. The fusion protein may also be applied to other collagenic graft materials, for use as a biomaterial for regenerating other tissues such as the skin.Type: GrantFiled: December 16, 2011Date of Patent: September 15, 2015Assignee: NANO INTELLIGENT BIOMEDICAL ENGINEERING CORPORATION CO, LTD.Inventors: Chong-Pyoung Chung, Yoon-Jeong Park, Jue-Yeon Lee, In Kyong Shim, Hyun Jung Park
-
Publication number: 20140377243Abstract: The present invention relates to a cell permeable fusion protein for strengthening regenerative potential of stem cells, and more particularly to a cell permeable fusion protein for strengthening regenerative potential of stem cells for stimulating the differentiation of stem cells, inhibiting apoptosis, maintaining the functionality of stem cells and restoring the stress-inhibited functionality of stem cells.Type: ApplicationFiled: December 16, 2011Publication date: December 25, 2014Applicants: NANO INTELLIGENT BIOMEDICAL ENGINEERING CORPORATION CO, LTD., SEOUL NATIONAL UNIVERSITY R AND DB FOUNDATIONInventors: Chong-Pyoung Chung, Yoon-Jeong Park, Jue-Yeon Lee
-
Publication number: 20130224128Abstract: The present invention relates to a dental cleanser composition for improving adhesion to teeth, and more particularly to, a dental cleanser composition which functions to remove not only a smear layer from the dentin surface of an exposed tooth root, but also oral bacteria, and thus is effective in improving adhesion to teeth in periodontal surgery. The present invention provides a dental cleanser composition containing sodium ethylene diaminotetraacetate and octyl phenol ethoxylate which is a surfactant. Sodium ethylene diaminotetraacetate in the composition functions to remove a smear layer on the tooth root surface and has antibacterial activity, and octyl phenol ethoxylate in the composition functions to lipopolysaccharide. Thus, the composition improves adhesion to teeth in periodontal surgery.Type: ApplicationFiled: February 28, 2011Publication date: August 29, 2013Applicant: NANO INTELLIGENT BIOMEDICAL ENGINEERING CO., LTD.Inventors: Chong-Pyoung Chung, Yoon-Jeong Park, Jue-Yeon Lee
-
Publication number: 20130210736Abstract: The present invention relates to a peptide having bone tissue regeneration capacity and binding to surface of apatite, and more particularly, to a peptide having bone tissue regeneration capacity and specifically binding to a surface of apatite mineral, capable of being stably immobilized to the surface of apatite mineral to retain effective activity and exhibit bone regeneration effects for a long time, by linking an amino acid sequence having bone tissue regeneration capacity and an amino acid sequence having apatite-binding capacity to each other to thereby provide a peptide having both bone-forming effects and binding capacity to the surface of apatite mineral, and a composition for bone tissue regeneration, containing the peptide.Type: ApplicationFiled: March 9, 2011Publication date: August 15, 2013Applicant: NANO INTELLIGENT BIOMEDICAL ENGINEERING CORPORATION CO., LTD.Inventors: Chong-Pyoung Chung, Yoon-Jeong Park, Sang Hoon Rhee, Jue- Yeon Lee
-
Publication number: 20120053129Abstract: The present invention relates to a target-activated cell/tissue-penetrating peptide for delivery of impermeable compounds (Target Activated Cell/tissue Translocation peptide for Impermeable Compound Strategy (TACTICS)), and the use thereof, and more particularly to a target-activated cell/tissue-penetrating peptide, which comprises (a) a protein transduction domain (PTD), (b) a masking domain and (c) a spacer having a cleavage site specific for a target cell/tissue enzyme and is provided with target selectivity so as to penetrate specifically into a target tissue, and to a conjugate of the peptide with a drug or drug-containing particles for imaging or therapeutic applications.Type: ApplicationFiled: February 19, 2010Publication date: March 1, 2012Applicant: NANO INTELLIGENT BIOMEDICAL ENGINEERINGInventors: Yoon-Jeong Park, Chong-Pyoung Chung, Victor C. Yang
-
Publication number: 20100317587Abstract: The present invention relates to an injectable bone regeneration material containing a bone formation enhancing peptide, and more particularly, to an injectable bone regeneration material, in which a bone formation enhancing peptide essentially containing one and more amino acid sequences among SEQ ID NO: 1 to SEQ ID NO: 28 is bonded or mixed to a gel-forming base material selected from the group consisting of chitosan, alginic acid, silk fibroin, propylene glycol, propylene glycol alginic acid, poloxamer, chondroitin sulphate, and the combination thereof. The injectable bone regeneration material according to the present invention can increase differentiation of bone marrow stromal cells and osteoblasts into bone tissue, thus maximizing tissue regeneration by a peptide capable of promoting differentiation of bone tissue and periodontal tissue regeneration. The injectable bone regeneration material is in the form of a gel, and thus can be applied to a surface of various medical devices such as implant etc.Type: ApplicationFiled: June 5, 2008Publication date: December 16, 2010Applicants: SEOUL NATIONAL UNIVERSITY INDUSTRY FOUNDATION, NANO INTELLIGENT BIOMEDICAL ENGINEERING CORPORATION CO., LTD.Inventors: Chong-Pyoung Chung, Yoon-Jeong Park, Jue-Yeon Lee